Weiguo Shi
Impact in
- Virology top 5%
- HIV Research and Treatment
- Toxicology top 10%
Papers in
-
- Pharmacological Receptor Mechanisms and Effects 8
- Cancer therapeutics and mechanisms 7
- Receptor Mechanisms and Signaling 4
- RNA and protein synthesis mechanisms 4
-
- Pain Mechanisms and Treatments 6
- Co-authors
- Keliang Liu (9 shared papers)Shibo Jiang (8 shared papers)Bo‐Hua Zhong (11 shared papers)Chengyun Yan (4 shared papers)Lifeng Cai (6 shared papers)Chao Wang (4 shared papers)Zhi Qi (2 shared papers)Chungen Pan (2 shared papers)
- Journals
- Molecules (5 papers)Chinese Chemical Letters (3 papers)Arabian Journal of Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)ChemMedChem (2 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Weiguo Shi
49 papers receiving 472 citations
Peers
Comparison fields: 5 of 85
- Virology 89
- Toxicology 20
- Infectious Diseases 101
- Pharmaceutical Science 24
- Microbiology 18
Countries citing papers authored by Weiguo Shi
This map shows the geographic impact of Weiguo Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Shi more than expected).
Fields of papers citing papers by Weiguo Shi
This network shows the impact of papers produced by Weiguo Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Shi. The network helps show where Weiguo Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiguo Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 47 | |
| 2 | 2018 | 46 | |
| 3 | 2013 | 22 | |
| 4 | 2023 | 20 | |
| 5 | [Study on interventing effect of puerarin on insulin resistance in patients with coronary heart disease]. | 2002 | 20 |
| 6 | 2021 | 19 | |
| 7 | 2014 | 15 | |
| 8 | 2012 | 15 | |
| 9 | 2018 | 15 | |
| 10 | 2016 | 14 | |
| 11 | 2009 | 14 | |
| 12 | 2008 | 13 | |
| 13 | 2019 | 13 | |
| 14 | 2004 | 11 | |
| 15 | 2019 | 11 | |
| 16 | 2019 | 11 | |
| 17 | 2016 | 11 | |
| 18 | 2016 | 11 | |
| 19 | 2017 | 11 | |
| 20 | 2017 | 10 |
About Weiguo Shi
Weiguo Shi is a scholar working on Molecular Biology, Physiology, Virology, Cellular and Molecular Neuroscience and Materials Chemistry, having authored 50 papers that have together received 483 indexed citations. Recurring topics across this work include Pharmacological Receptor Mechanisms and Effects (8 papers), HIV Research and Treatment (7 papers), Cancer therapeutics and mechanisms (7 papers), Pain Mechanisms and Treatments (6 papers), Neuropeptides and Animal Physiology (6 papers), Bioactive Compounds and Antitumor Agents (4 papers), Receptor Mechanisms and Signaling (4 papers) and RNA and protein synthesis mechanisms (4 papers). The work is most often cited by research in Virology (89 citations), Toxicology (20 citations), Infectious Diseases (101 citations), Pharmaceutical Science (24 citations) and Microbiology (18 citations). Weiguo Shi has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Keliang Liu, Shibo Jiang, Bo‐Hua Zhong, Chengyun Yan, Lifeng Cai, Chao Wang, Zhi Qi, Chungen Pan, Na Xue and Weiguo Jing. Their work appears in journals such as Molecules, Chinese Chemical Letters, Arabian Journal of Chemistry, Bioorganic & Medicinal Chemistry Letters and ChemMedChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.